ArticleClinical breast cancer2016

Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy.

Komal Jhaveri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.